Archive for December 2016

Talcum Powder Lawsuits: No Seasonal Cheer for J&J

talcum powder litigation update

This season is stressful for all the wrong reasons at Johnson and Johnson, who had more talcum powder lawsuits to handle as we entered the holidays.  After losing several cases in a row earlier this year, the pharmaceutical giant will now face two new charges of negligence related to talcum powder. The two lawsuits, filed…

Read More

Inappropriate Antibiotics and the Fluoroquinolone Problem

fluoroquinolone problem

The fluoroquinolone problem is a familiar story in the US pharmaceutical sector; a product so effective that it becomes prescribed across the board. Fluoroquinolone antibiotics like Levaquin, Avelox, and Cipro are broad spectrum, which means they’re more effective against infections that can be resistant to other forms of antibiotics. That means they have a wide…

Read More

Coast-to-Coast, Taxotere Lawsuits Sweep the Country

chemotherapy patient female with makeup

Taxotere lawsuits are being filed around the country. In the last two months alone, new legal complaints have been filed by women in California and Oklahoma, while more than 180 cases continue to move through courts in Louisiana. The cases are filed by breast cancer patients who have experienced hair loss as a side effect…

Read More

Risperdal Walks the Legal Line


Image Credit: David Andrew Copeland With more than 15,000 Risperdal lawsuits out there, the legal team at pharmaceutical giant Johnson and Johnson (J&J) has been busy addressing the drug’s side effects this year. Chief among them is gynecomastia, a condition that afflicts young males with enlarged breast tissue due to an increase in estrogen levels.…

Read More

Appeal Dismissal Ensures Zofran Lawsuits Continue Into 2017

baby's feet in mother's hands

Zofran lawsuits continue apace, despite GlaxoSmithKline’s (GSK) best efforts to have them quashed.  For several months now, GSK has made the claim that five lawsuits prompted by birth defects should be dismissed by Judge F. Dennis Saylor IV in Massachusetts. The pharmaceutical company’s belief is that the plaintiffs failed to file key records and documentation…

Read More

Xarelto Receives Mixed Press as 2016 Comes to a Close

Janssen Pharma Office Netherlands

Most drugs are subject to varied press coverage over their lifetime. Blood-thinner Xarelto is no exception, as the latest research and legal challenges jockey for headline position as the year draws to a close. First, the good news… This week a new analysis of the drug’s impact on blood clots found cancer patients treated with…

Read More

Study: Pradaxa Drug Increase Risk of Bleeding

different color pills with prescription bottle

A new study by researchers in Canada suggests that the blood-thinning drug Pradaxa, when combined with other medications, can increase the chance of internal bleeding. Published in the Canadian Medical Association Journal (CMAJ) last month, the study covered 45,991 patients in Ontario, all of whom were 66 or older and took Pradaxa to manage their…

Read More